✦ LIBER ✦

Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study

✍ Scribed by Antonella Poloni; Debora Capelli; Silvia Trappolini; Benedetta Costantini; Mauro Montanari; Guido Gini; Ilaria Scortechini; Giorgia Mancini; Giancarlo Discepoli; Pietro Leoni; Attilio Olivieri

Book ID: 108676762
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 99 KB
Volume: 150
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08168.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemtuzumab ozogamicin as maintenance the

Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia

✍ Nicola Cascavilla; Giovanni D’Arena; Michele Mario Greco; Lorella Melillo; Emanu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

A Phase 2 study of combination therapy w

A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia

✍ Mikkael A. Sekeres; Jaroslaw P. Maciejewski; Harry P. Erba; Manuel Afable; Ricki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

Adding low-dose gemtuzumab ozogamicin to

Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients

✍ Marino Clavio; Luana Vignolo; Alessandra Albarello; Riccardo Varaldo; Ivana Pier 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Randomized trial of two schedules of low

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)

✍ Sergio Amadori; Stefan Suciu; Dominik Selleslag; Roberto Stasi; Giuliana Alimena 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Fractionated doses of gemtuzumab ozogami

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70-year old: A phase 1/2 study of the acute leukemia French association

✍ Hassan Farhat; Oumedaly Reman; Emmanuel Raffoux; Celine Berthon; Cécile Pautas; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

Feasibility of peripheral blood stem cel

Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group

✍ Marco Montillo; Alessandra Tedeschi; Livio Pagano; Adriano Venditti; Felicetto F 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB